Agencies post cancer drug data online

Mark McClellan

The Food and Drug Administration and the National Cancer Institute are teaming up to build a grid-computing system that will let drug researchers share developmental data about cancer drugs.

The initiative will let researchers electronically submit applications to investigate new drugs, FDA commissioner Mark McClellan said.

It also will give cancer researchers online access to FDA's drug review databases, letting them evaluate clinical trial data, he said.

The effort is part of NCI's broader online initiative, the Cancer Biomedical Informatics Grid Project.

McClellan described the data-sharing project earlier this month at a meeting of the President's Information Technology Advisory Committee in Arlington, Va.

For more information about the grid project, visit

Stay Connected

Sign up for our newsletter.

I agree to this site's Privacy Policy.